Related by context. All words. (Click for frequent words.) 67 HepaMate ™ 66 Empatic ™ 65 kidney urologic 65 eprodisate Fibrillex TM 65 BrachySil TM 65 LymphoStat B belimumab 65 Bayer HealthCare Onyx Pharmaceuticals 65 acadesine 65 INTEGRILIN R eptifibatide Injection 65 Curaxin CBLC# 64 PrevOnco ™ 64 GTC recombinant human 64 candidate TNFerade biologic 64 successfully commercialize Iluvien 64 LAB CGRP 64 HuMax TAC 64 oral ghrelin agonist 64 Zemplar Capsules 64 novel therapeutic antibodies 64 pain palliation 64 inhaled AAT 64 MyoCell 64 BrachySil ™ 64 acyclovir Lauriad R 64 recombinant PSMA vaccine 64 clinical trials Archexin 64 Inhaled nitric oxide 63 HDL Selective Delipidation 63 HepaMate 63 Brinavess 63 MelaFind R 63 PRESEPT study 63 mertansine 63 antibody MAb 63 Novolimus 63 rALLy clinical trial 63 MyoCell SDF 1 63 EMPOWER ™ 63 BGM Galectin 3 63 Diamyd R 63 humanised antibody 63 accumulate preferentially 63 Crofelemer budesonide foam 63 either acutely decompensated 63 PhG alpha 1 63 cathepsin K inhibitor 63 BCG refractory carcinoma 63 initiate multicenter 62 YONDELIS 62 generation rotary VAD 62 Prodarsan R 62 Artificial pancreas 62 Archexin 62 paclitaxel poliglumex 62 PLX STROKE targeting 62 aerosolized AAT 62 Prolastin A1PI 62 TBC# 62 SomatoKine 62 Mipomersen 62 Fibrin Pad 62 StemEx 62 pharmacogenomic translational research 62 EchoCRT 62 MAGE A3 ASCI 62 MYDICAR ® 62 MIST II 62 INTERCEPT red 62 bioengineered tissue 62 AERx ® 62 Gamunex C 62 Tectin TM 62 StemEx R 62 endothelin antagonist 62 adipose derived stem cell 62 approved incretin mimetic 62 Vascugel 62 deCODE AF TM 62 methylnaltrexone bromide 62 ospemifene 62 octreotide implant 62 humanized therapeutic 61 reslizumab 61 CBLC# 61 Lixivaptan 61 PHX# 61 OncoGel 61 EVIZON TM 61 recombinant soluble 61 CCR9 antagonist 61 oral talactoferrin 61 Surfaxin LS 61 riociguat 61 Phase #b/#a clinical 61 MyoCell ® 61 Achieves Primary Endpoint 61 treat lupus renal 61 oral rivaroxaban 61 next generation URAT1 61 GRNOPC1 contains 61 Simulect 61 Rilonacept 61 Spiegelmer ® 61 CTAP# Capsules 61 Ceragenin ™ 61 potent topoisomerase II 61 targeted radiotherapeutic 61 CRMD# 61 IMPDH inhibitor 61 immunotherapeutic vaccine 61 albiglutide 61 fully bioabsorbable 61 rhIGF-I/rhIGFBP-3 61 implantable centrifugal rotary 61 DEEP AF 61 registrational Phase 61 delivers fluocinolone acetonide FA 61 Dabigatran etexilate 61 proprietary bioresorbable polymer 61 Urocidin 61 HCV NS5B polymerase 61 mesylate tablets approved 61 AKT inhibitor 61 personalized cellular immunotherapy 61 GTC recombinant form 61 Phase IIb clinical trials 61 Silodosin 61 blood clot dissolver 61 Prosaptide 61 GLP1 agonist 61 Cx# [002] 61 ReN# 61 midstage clinical 61 Degarelix 61 Zolpimist ™ 61 QTinno TM 61 Juvaris BioTherapeutics 61 aldehyde dehydrogenase ALDH2 deficiency 61 dose escalation clinical 61 candidates Azedra TM 61 davalintide 61 deCODE ProstateCancer TM 61 rhFVIIa 60 Phase #b/#a 60 oral methylnaltrexone 60 nalbuphine ER 60 therapeutic monoclonal antibody 60 TOCOSOL Camptothecin 60 immunotherapeutic agent 60 Pirfenidone 60 adrenergic regulation 60 MKC# 60 Valtropin 60 QNEXA ® 60 Prodarsan ® 60 class mGluR5 inhibitor 60 Phase III multicenter 60 Fx #A 60 Plasmin 60 apricitabine ATC 60 somatostatin analog 60 STRIDE PD 60 granted Ortec 60 vapreotide acetate 60 MEND CABG II 60 systemic immunosuppressive drugs 60 transmucosal delivery system 60 Deforolimus 60 Aeolus Pharmaceuticals Announces 60 BCR ABL inhibitor 60 OraTest R 60 SGLT Inhibitors 60 Bellicum 60 Perforomist TM formoterol fumarate 60 Revascor ™ 60 carbohydrate polymers 60 perfluorocarbon PFC therapeutic 60 ENABLE Phase 2 60 sapacitabine CYC# 60 relapsed MM 60 riboflavin vitamin B2 60 RenalGuard Therapy 60 cellular immunotherapy 60 ChronVac C R 60 Rheos System 60 PF # [002] 60 PROCHYMAL 60 biologic antibody 60 benign prostatic hyperplasia enlarged 60 IIa trials 60 optimal dosing regimens 60 Evoltra ® 60 NeuroSTAT ® 60 PEGylated interferon 60 R#/MEM # 60 acetonide FA 60 oral picoplatin 60 Triapine 60 NP2 Enkephalin 60 HuCNS SC ® 60 GVAX ® 60 HepDirect prodrug 60 Lofexidine 60 Litx 60 Cand5 60 IIa clinical trials 60 NEBIDO VANTAS SUPPRELIN LA 60 ONCONASE R 60 human IgG1 monoclonal 60 ATPace TM 60 APEX PD 60 multicenter Phase II 60 GED aPC 60 hepatitis B immune globulin 60 recurrent metastatic ovarian cancer 60 nucleotide analog 60 Abbokinase 60 oncolytic virus therapies 60 NeuroFlo 60 azilsartan medoxomil 60 INOmax 60 vinorelbine tartrate 60 CINQUIL 60 chronic thromboembolic pulmonary 60 solid tumors ZYBRESTAT 60 OMAPRO ™ 60 PI3K/Akt pathway inhibitor 60 AAG geldanamycin analog 60 rotary VAD 60 oral PTH 60 PROVENGE ® 60 Zalypsis 60 AdhTAP 60 RhuDex R 60 A1PI 60 R sorafenib tablets 60 AIDS prophylaxis congestive 60 Xcellerated T Cells 60 Levacor TM 60 ® natalizumab 60 OncoVex 60 DEB# 60 non peptidic protease 59 Capesaris 59 selective A2A adenosine receptor 59 ABSORB clinical 59 MGN# 59 OMNARIS HFA 59 budesonide MMX Phase III 59 confirmatory clinical 59 mGluR2 positive 59 multicenter dose escalation 59 Hemospan 59 CVac 59 opioid induced bowel dysfunction 59 LUNESTA brand eszopiclone 59 TNF Tumor Necrosis Factor 59 Fibrin MB 59 CEL SCI Phase III 59 CYT# potent vascular disrupting 59 product Zingo TM 59 GRN# 59 Fodosine 59 Argatroban 59 hyaluronidase enzyme 59 acute mania 59 Zavesca r 59 Soliris eculizumab 59 Duromist ™ 59 NPC 1C 59 cetrorelix pamoate 59 Liprotamase 59 albiglutide currently 59 undergoing elective percutaneous 59 recombinant biopharmaceutical 59 encapsulated porcine insulin 59 Cerashield TM 59 STEDESA 59 Initiates Phase II 59 CDAD Clostridium difficile 59 Phase Ib IIa 59 Certican 59 RhuDex ® 59 Cardio Vascu Grow 59 VALSTAR 59 evaluating T DM1 59 HuMax CD#b 59 ACTEMRA TM 59 Iluvien ® 59 Alvesco R 59 Vascugel ® 59 regorafenib 59 Ceplene/IL-2 59 thorough QT 59 SEPET TM 59 Elagolix 59 ADVANCE PD 59 PSMA ADC 59 ancrod 59 ImmunoGen TAP technology 59 Alferon N 59 AERx R 59 Factor XIII 59 metaglidasen 59 Phase #b/#a trial 59 Oral NKTR 59 farletuzumab 59 Allovectin 7 59 Orosi Mill project 59 SinuNase ™ 59 Tarceva TM 59 Bosutinib 59 ThermoDox R 59 GLPG# 59 VBLOC vagal blocking 59 Ozarelix 59 Ixempra 59 OHR/AVR# 59 CEQ# 59 metastatic colorectal 59 prospective randomized multicenter 59 LibiGel Phase III 59 NeuVax 59 EHT AGN 59 fusion enhancers 59 Diamondback #deg 59 Nanobody R 59 Phase Ib clinical trials 59 Budesonide foam crofelemer 59 SinuNase TM 59 TELINTRA R 59 BrachySil 59 Acetavance TM intravenous acetaminophen 59 basal bolus therapy 59 Albuferon albinterferon alfa 2b 59 INSPIRE Trial Phase III 59 Ketotransdel 59 Human cl 59 Myoblast Program 59 Collategene 59 intravenous AAT 59 metastatic pancreatic 59 CCR5 mAb 59 liver resection surgeries 59 HCV RNA polymerase 59 include ColorectAlert TM 59 Enkephalin 59 highly purified pasteurized 59 undergoing hematopoietic stem 59 Personalized Immunotherapy 59 Amrubicin 59 targeted antifolate 59 Insegia 59 overactive bladder AA# 59 Prestara 59 CIPN 59 GeneICE 59 Stereotaxis System 59 Aflibercept 59 vivo toxicology 59 XL# anticancer compounds 59 lucinactant 59 systemic hypotension 59 potent suppressor 59 Civacir 59 eligen 59 BioNumerik 59 pivotal bioequivalence 59 unresectable liver cancer 59 delivery polymer matrix 59 Dextofisopam 59 initiate Phase IIa 59 proprietary intranasal insulin 59 MKC# MKC# PP 59 HepeX B 59 Phase IIIb clinical 59 Diamyd r 59 HGS# 59 membranous nephritis 59 Thorough QT 59 Lysteda 59 treat chronic sinusitis 59 AFREZZA TM 59 POWERSTACK tm MC# 59 vivo validation 59 DCVax R 59 rhITF 59 Nexavar sorafenib tablets 59 oral deforolimus 58 Prodarsan 58 OncoVEX 58 ATD gel 58 LungAlert TM 58 Efficacy Trial 58 purine analog 58 Diabetic Foot Ulcer 58 demonstrated antitumor activity 58 vidofludimus 58 multicenter Phase III 58 Monoclonal antibody 58 Excellarate TM 58 CIMZIA ™ 58 Bioral 58 CYT# QbG# 58 AERAS-#/Crucell Ad# 58 Qutenza TM 58 phase IIa clinical 58 DG# compounds targeting 58 tolevamer 58 Tarvacin Anti Cancer 58 Meets Primary Endpoint 58 Spiegelmer 58 Peyronie disease Frozen Shoulder 58 vaccine GMK 58 insulin parathyroid hormone 58 tezampanel NGX# 58 Liposomal Grb 2 58 Phase IIb III 58 TBC M4 58 Prochymal TM 58 bioartificial liver 58 synthetic peptide containing 58 intravesical infusion therapy 58 ZOLL resuscitation product 58 oral Janus kinase 58 Interferon beta 58 structure infections ABSSSI 58 CA9 SCAN 58 Aptivus ® 58 MAXY VII 58 candidate deforolimus 58 rhMBL 58 VANTAS ® 58 Somatuline Depot 58 OLpur TM H2H 58 PD2i Analyzer 58 MGd 58 Wyeth Progenics 58 Vitrasert R 58 BRIM2 58 oxypurinol 58 Aloprim TM allopurinol sodium 58 CFTR corrector 58 Angiocept 58 ZOLINZA 58 EC Cysteamine 58 FUSILEV enhances 58 BioSTAR ® 58 dirucotide MBP# 58 ANAVEX #-# [001] 58 Diamyd ® 58 Medidur TM FA 58 skeletal sarcomere activators 58 neovascularisation 58 Factor VIIa 58 pharmacokinetic PK study 58 novel peptides 58 SERCA2a gene 58 interferon alpha IFN 58 dyslipidemia hypertension diabetes 58 Daclizumab 58 E1 INT TM 58 HQK 58 selective androgen receptor modulator 58 Poly ICLC 58 tramiprosate Alzhemed TM 58 PICM 58 Phase 1a clinical 58 unique alkylating agent 58 Perceiva 58 juvenile chondrocytes 58 SERCA2a 58 syndrome overactive bladder 58 patients receiving myelosuppressive 58 Tengion Neo Urinary Conduit 58 pan BCR ABL 58 Testosterone MDTS R 58 GAMMAGARD 58 miconazole Lauriad ® 58 Vernakalant 58 RECOTHROM ® 58 GLP toxicology studies 58 sorafenib tablets 58 NADiA 58 liposomal formulation 58 novel immunotherapies 58 phase IIb clinical 58 Anthim 58 pyrimidine nucleoside analog 58 IMiDs ® 58 novel VDA molecule 58 Umbilical cord stem cells 58 Urocidin TM 58 ASCEND HF 58 Neo Bladder Augment 58 Currently RegeneRx 58 Smac mimetics 58 SNT MC# 58 PORxin TM platforms 58 thrombopoietin TPO 58 CytoFabTM 58 RANK Ligand inhibitor 58 Exelixis compounds 58 Curaxin 58 IMC #B 58 zileuton injection 58 Initiates Clinical 58 Initiates Enrollment 58 Multiple Ascending Dose 58 novel oral anticoagulant 58 aerosolized KL4 surfactant 58 Arzerra ofatumumab 58 tubulin inhibitor 58 samalizumab 58 Tykerb lapatinib 58 forodesine 58 Gleevec resistant 58 mTOR kinase 58 drug figitumumab 58 phase Ib 58 sulfonylurea glimepiride 58 Small Modular SMIP 58 HGS ETR1 mapatumumab 58 cannabinor 58 inhibit oxidative stress 58 Kahalalide F 58 NPM1 mutation 58 hESC derived 58 bipolar wafer 58 hepatitis C viral infection 58 targeting miR 58 CellCept mycophenolate mofetil 58 VersaFilm 58 CRD5 58 Selective Electrochemical Tumor Ablation 58 Sonatherm 58 HuCAL antibodies 58 PYY nasal spray 58 BFPET 58 relapsing remitting MS RRMS 58 Bendamustine 58 LEVADEX ™ 58 GeoVax AIDS vaccine 58 budesonide foam 58 MUSE ® 58 MDS AML 58 Oral Calcitonin 58 lupus renal disease 58 asymptomatic hyperuricemia 58 OvaRex R 58 cardio metabolic diseases 58 ZYBRESTAT fosbretabulin 58 Initiate Phase 58 Lucanix R 58 Vasogen Celacade TM 58 humanised monoclonal antibody 58 KYNAPID 58 Phase 2b clinical trials 58 Bexion 58 ® bortezomib 58 Cerashield ™ 58 SPL# Gel vaginal microbicide 58 Granulocyte Colony Stimulating Factor 58 Pertuzumab 58 cat dander allergy 58 dose escalation phase 58 iBioLaunch platform 58 HuMax 58 GATTEX ™ 58 Pruvel TM 58 regenerative therapy 58 RELOVAIR ™ 58 Phase 2a clinical trials 58 lowering triglyceride levels 58 Pitavastatin 58 Gentamicin Surgical Implant 58 receptor tyrosine kinase inhibitor 58 agents Tabun Sarin 58 CoAxia 58 Cethromycin 58 Dyloject TM 58 Vectibix panitumumab 58 dexanabinol 57 Canvaxin 57 oral prodrug 57 preclinical efficacy 57 selectively inhibit replication 57 Genz # 57 Olaparib 57 Luveniq 57 Phase III ADT 57 Biopump 57 TransVax 57 Noxafil 57 telomerase therapeutic 57 randomized Phase IIb 57 canakinumab 57 Regenerative Cell 57 orally inhaled 57 novel nucleoside analog 57 Aerosurf 57 Unigene nasal calcitonin 57 Fabry Disease 57 recombinant erythropoietin 57 beta islets 57 DepoVax TM 57 LymphoStat B TM 57 JAK#/JAK# inhibitor CYT# 57 Chemophase 57 Unit Dose Budesonide 57 refractory colorectal cancer 57 Phase Ib clinical 57 CIMZIA TM 57 subcutaneously administered 57 Elestrin ® 57 Ganciclovir 57 Tasigna prolongs 57 Trastuzumab DM1 57 novel emulsion formulation 57 THR beta agonist 57 reduce serum phosphate 57 cromolyn sodium 57 PrevOnco 57 GENASIS 57 SomatoKine R 57 initiated Phase Ib 57 Xcytrin R 57 ImmuKnow R 57 Phase 1b clinical trials 57 Ocrelizumab 57 Proxinium TM 57 visilizumab 57 BEXXAR Therapeutic Regimen 57 Medidur FA 57 vaso occlusive crisis 57 maximally tolerated dose 57 Anavex #-# 57 Salix Pharmaceuticals Announces 57 NS5B polymerase 57 overactive bladder VANTAS R 57 fibrin deposition 57 immune modulating 57 coronary stent merged 57 AEG# 57 alvespimycin 57 Aeroquin 57 cGMP manufacture 57 cilengitide 57 cosmetic cosmeceutical products 57 5 HT4 57 Quinamed 57 ClearPath TM 57 docetaxel Taxotere ® 57 Endotis 57 Canvaxin TM 57 SUTENT ® 57 C1INH 57 Methylnaltrexone 57 includes TOLAMBA TM 57 Omapro 57 Warfarin Coumadin 57 motesanib 57 Captisol ® 57 Protexia ® 57 TransMID 57 Phase IIB 57 synthetic retinoid 57 Alfimeprase 57 constipation OIC 57 Hexvix ® 57 VA# [002] 57 commercialize deforolimus 57 anti botulism antibody 57 Oncotype DX colon cancer 57 plus prednisone prednisolone 57 NP2 57 thetreatment 57 EVIZON TM squalamine lactate 57 recurrent glioblastoma multiforme 57 oral antiplatelet agent 57 sargramostim 57 Eniluracil 57 refractory metastatic 57 DITPA 57 omega interferon 57 PYY #-# 57 AcryMed Incorporated 57 ALTROPANE R 57 Oxycyte TM 57 Meritage Pharma 57 RenaZorb TM 57 Entereg TM 57 torezolid phosphate 57 MTP inhibitor 57 GetGoal Phase III 57 randomized discontinuation 57 alpha1 antitrypsin deficiency 57 generation purine nucleoside 57 CHAMPION PCI 57 IMA# 57 KIACTA ™ 57 RSD# oral 57 protein tyrosine phosphatase 1B 57 Azmacort R 57 Phase III HEAT 57 Cojocaru correspondent 57 Bezielle 57 Muraglitazar 57 PDE4 inhibitor 57 Phase III Pivotal 57 concurrent chemoradiation 57 Neovasc Reducer 57 Coronary stent 57 Traficet EN 57 Proellex TM 57 Bystolic nebivolol 57 miconazole Lauriad R 57 MYDICAR 57 Virulizin ® 57 EGFr humanized monoclonal antibody 57 MOVIPREP R 57 Vidofludimus 57 Cerimon Pharmaceuticals Inc. 57 lomitapide 57 ProCord 57 PGL# 57 glycoprotein IIb IIIa inhibitor 57 QTinno 57 Generx TM 57 Enhanze 57 evaluating tivozanib 57 MVax 57 Bioral Amphotericin B 57 ZFP Therapeutics 57 PANVAC VF 57 Advancing Wellness 57 Technosphere ® 57 efaproxiral 57 trodusquemine 57 Ataluren 57 agonistic human 57 E2F Decoy 57 renin inhibitor 57 smoldering multiple myeloma 57 Novo TTF 57 About Positron Positron 57 Saforis 57 pharmacodynamic effects 57 Diamyd r vaccine 57 Wellmune WGP 57 phase IIa 57 Exherin TM 57 BEMA TM Fentanyl 57 NAVISTAR R 57 Phase III confirmatory 57 IONSYS TM 57 topical agent Xantryl 57 Levacor 57 peptide receptor 57 intranasal insulin 57 Staphylococcus aureus Polysaccharide Conjugate 57 RhuDex 57 Endologix Powerlink System 57 bardoxolone 57 ThGRF 57 thorough QTc 57 mda 7 57 ZFP TF 57 ACCLAIM II 57 Hsp# Inhibitor 57 AVONEX PEN 57 Recurrent Glioblastoma 57 #L Sterilizer 57 triggers apoptosis programmed 57 UPLYSO 57 Skin Cholesterol Test 57 PROMUS Element Stent 57 Biomerix Corporation 57 beta 1a 57 TRIOLEX HE# APOPTONE HE# 57 IRX 2 57 biliary tract cancer 57 lenalidomide Revlimid R 57 Resten NG 57 Successfully Completes Phase 57 receptor inhibitor 57 pralatrexate injection folate analogue 57 Empatic TM 57 severe oral mucositis 57 related CMV Retinitis 57 product platforms AZX# 57 TRO# 57 sporicidal product 57 Teysuno 57 Perforomist ™ Inhalation Solution 57 dimebon latrepirdine 57 EOquin TM phase 57 Safinamide 57 Omacetaxine 57 interferon beta therapy 57 dorzolamide 57 TRAIL receptor antibody mapatumumab 57 bortezomib Velcade 57 Neuvenge 57 rhThrombin 57 EDEMA3 trial 57 Restanza TM 57 liprotamase 57 AE# vaccine 57 Nicole Onetto MD 57 malignant mesothelioma Alfacell 57 Septin9 biomarker 57 Provectus Pharmaceuticals specializes 57 Atrasentan 57 gamma secretase inhibitor 57 clonogenic 57 Convivia TM 57 name Cetrotide R 57 drug GAP #B# 57 YONDELIS R 57 investigational humanized monoclonal antibody 57 Anticalins R 57 Aplidin 57 drug eluting coronary stent 57 HDL Mimetic Peptide 57 pafuramidine 57 Onalta ™ 57 intranasal formulation 57 zileuton IV 57 tiapamil 57 acyclovir Lauriad ® 57 subcutaneous PRO 57 Val HeFT 57 PNP inhibitor 57 experimentally induced 57 thrombopoietin TPO natural 57 Catena ® 57 drug NP2 Enkephalin 57 QLT Plug Delivery 57 SEQureDx ™ 57 folate analogue metabolic 57 MKC# MT 57 PediaFlow 57 delta opioid receptor 57 REG2 57 torsemide ER 57 vitro pharmacology 57 REVIVE Diabetes 57 ACCORD Eye 57 5 fluorouracil leucovorin 57 ulimorelin 57 Amphinex ® 57 Oracea TM 56 anticoagulant reversing agent 56 dose intramuscular 56 INS# [001] 56 DexaSite 56 trial evaluating PRX# 56 hereditary deficiency 56 subcutaneous ORENCIA 56 TaiGen 56 rotavirus shingles 56 treating peripheral arterial 56 compound INCB# 56 rxRNA 56 immune modulator 56 GRNCM1 56 PSN# [001] 56 Pancreate 56 iobenguane 56 Dapagliflozin 56 Soluble CD# 56 Mg Usa 56 EP #R 56 Phase IIa trials 56 LHRH antagonist 56 Microplasmin 56 pegylated recombinant 56 Telatinib 56 pseudobulbar affect PBA 56 histamine dihydrochloride 56 Denufosol 56 ReN# stem cell 56 NTDDS 56 Spheramine 56 Epratuzumab 56 oral renin inhibitor 56 ACCEDE 56 Arikace 56 VitiGam 56 cancer immunotherapies 56 PD LID 56 HCV protease inhibitors 56 Initiates Phase III 56 opioid naive 56 chimeric monoclonal antibody 56 LHRH receptor positive 56 Pyridorin 56 cancer neuroendocrine tumor 56 immune modulatory 56 Erimos 56 denileukin diftitox 56 Leydig cells 56 TKM PLK1 56 Granted Orphan Drug 56 brand ciclesonide HFA 56 factor VIIa 56 ATryn ® GTC recombinant 56 trastuzumab DM1 T DM1 56 banned Darvon Darvocet 56 intranasal insulin product 56 Ceflatonin R 56 Thalomid ® 56 ATL# [001] 56 proprietary PEGylation 56 Malignant Glioma 56 Omigard 56 Nipent R 56 SNT-MC#/idebenone 56 buccal delivery 56 hypoxia activated prodrug 56 ATryn GTC 56 PTH analogue 56 Ribavirin causes 56 immunotherapeutic approaches 56 DUROS 56 TFChem licenses 56 catheter occlusion 56 GeoVax vaccine 56 sitaxsentan 56 anagrelide 56 RLY# 56 Cumulase 56 transoral 56 Lisofylline LSF 56 OvaRex 56 doxorubicin Transdrug ® 56 Pervasis 56 INOmax R 56 CMV vaccine 56 cytidine nucleoside analog 56 DPX Survivac 56 MicuRx 56 AFRS TM 56 thymosin beta 4 56 M# rationally 56 bioFILM PA TM 56 Hepatocellular Carcinoma HCC 56 NurOwn 56 thrombin inhibiting aptamer 56 MEND CABG 56 Phase IIA 56 GI motility disorders 56 CardioPET 56 cancer related hypercalcemia 56 5 lipoxygenase inhibitor 56 ACE Inhibitor 56 Squalamine 56 MEPACT 56 afamelanotide 56 ABSORB trial 56 dialed Ybarra 56 basal bolus regimen 56 opioid bowel dysfunction 56 included exfoliative dermatitis 56 Panzem R NCD 56 Phase Ib II 56 autoimmune encephalitis 56 Independently Dyax 56 Shows Promise Against 56 Vicinium TM 56 incyclinide 56 EGS# 56 placebo controlled multicenter 56 bavituximab monotherapy trial 56 investigational monoclonal antibody 56 commercialize CorMedix drug 56 Genzyme Synvisc 56 Advanced Heart Failure 56 Neupogen ® 56 Ophena 56 Vaxfectin 56 Skin grafting 56 anti CD3 antibody 56 adjuvant GIST 56 Indomethacin 56 Company patented BEMA 56 oral dnaJP1 56 OvaDx 56 Phase IIa proof 56 BHT DNA 56 Anturol TM 56 Thelin tm 56 ViaDerm hPTH #-# 56 R Saizen R 56 Testosterone MDTS ® 56 ovulation fertilization 56 nasal calcitonin product 56 Phase lll